Attorneys at Our Firm
Serving Clients Throughout Georgia and South Carolina

Articles Tagged with Johnson & Johnson

A recently filed lawsuit claims breast implants manufactured by Mentor Worldwide, a Johnson & Johnson subsidiary, caused an Ohio woman to develop a rare form of cancer known as anaplastic large cell lymphoma, or ALCL.  Johnson and Johnson purchased Mentor in 2009 for more than $1.1 billion.

According to the complaint, Renee Cashen, 45, of Ashville, Ohio, had breast implant surgery in February 2008. About eight years later, she noticed a lump under her right armpit and a biopsy determined she had anaplastic large cell lymphoma.  She had surgery to remove the MemoryGel® SILTEX® implants, made by Mentor, as well as infected lymph nodes. She subsequently underwent chemotherapy for a condition that has become known as Breast Implant-Associated Anaplastic Large Cell Lymphoma, or BIA-ALCL.

Ms. Cashen is one of many women across the country who has experienced health problems related to implants. In March of 2018, the FDA issued a warning to individuals with breast implants alerting them to the potential link to BIA-ALCL. As of September 30, 2017, the FDA had received a total of 414 medical device reports (MDRs) of BIA-ALCL, including the death of nine patients.